Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-02-04

FDA Approved: NEVIRAPINE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for NEVIRAPINE from Aurobindo Pharma Limited, authorizing an additional regulatory action on this generic HIV-1 medicati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEVIRAPINE (nevirapine)

Snippet

SUPPL AP for NEVIRAPINE (NEVIRAPINE)